1. Home
  2. RAYA vs LSTA Comparison

RAYA vs LSTA Comparison

Compare RAYA & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Erayak Power Solution Group Inc.

RAYA

Erayak Power Solution Group Inc.

N/A

Current Price

$2.32

Market Cap

2.6M

ML Signal

N/A

Logo Lisata Therapeutics Inc.

LSTA

Lisata Therapeutics Inc.

N/A

Current Price

$1.09

Market Cap

28.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RAYA
LSTA
Founded
2019
1980
Country
China
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Misc Health and Biotechnology Services
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6M
28.9M
IPO Year
2021
2000

Fundamental Metrics

Financial Performance
Metric
RAYA
LSTA
Price
$2.32
$1.09
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$15.00
AVG Volume (30 Days)
36.4K
96.4K
Earning Date
04-17-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
20.42
EPS
N/A
N/A
Revenue
N/A
$35,283,868.00
Revenue This Year
$20.95
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
56.90
52 Week Low
$0.03
$0.99
52 Week High
$10.14
$5.07

Technical Indicators

Market Signals
Indicator
RAYA
LSTA
Relative Strength Index (RSI) 39.81 27.13
Support Level $2.05 $0.99
Resistance Level $2.95 $1.28
Average True Range (ATR) 0.24 0.11
MACD 0.01 0.08
Stochastic Oscillator 21.27 38.01

Price Performance

Historical Comparison
RAYA
LSTA

About RAYA Erayak Power Solution Group Inc.

Erayak Power Solution Group Inc is engaged in the manufacturing, research and development (R&D), and wholesale and retail of power solution products. The group focuses on manufacturing new energy storage and inverter devices. Its product portfolio includes sine wave and off-grid inverters, inverters and gasoline generators, battery and smart chargers, and custom-designed products. The products are used principally in agricultural and industrial vehicles, recreational vehicles (RVs), electrical appliances, and outdoor living products. The company generates the majority of its revenue from Inverters. The company generates revenue from five main markets, which are China, Poland, Mexico, the U.K., and Portugal. It derives maximum revenue from China.

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.

Share on Social Networks: